Conversely, HMGCR was expressed at high levels in well-established pluripotent stem cell models as well as CSC lines from glioblastoma, suggesting that HMGCR might be a marker of acquired stem phenotypes in transformed and non-transformed cells. The gene discussed is HMGCR; the disease is glioblastoma.